Related Experiment Video
Updated: Oct 18, 2026
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Current markers of myocardial ischemia and their validity in end-stage renal disease
1Renal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Insights
Diagnosing heart disease in end-stage renal disease patients is challenging. Troponin I is the most sensitive and specific marker for detecting cardiac ischemia in this population.
Area of Science:
- Cardiology
- Nephrology
- Biomarker Analysis
Background:
- Coronary artery disease (CAD) is a major cause of death in end-stage renal disease (ESRD) patients.
- Diagnosing myocardial disease in ESRD is difficult due to abnormal EKGs and atypical symptoms.
- Conventional cardiac injury markers lack specificity in ESRD patients.
Purpose of the Study:
- To evaluate the diagnostic utility of cardiac troponins for myocardial ischemia in ESRD patients.
- To identify the most reliable biomarker for detecting cardiac injury in this population.
Main Methods:
- Review of existing literature on cardiac biomarkers in ESRD.
- Comparison of the specificity and sensitivity of creatinine kinase-muscle brain enzyme, troponin T, and troponin I.
- Analysis of biomarker performance in the context of abnormal baseline EKGs and silent ischemia.
Main Results:
- Creatinine kinase-muscle brain enzyme shows nonspecific elevations in ESRD.
- Cardiac troponin T exhibits poor specificity in ESRD patients.
- Troponin I demonstrates high sensitivity and specificity for cardiac ischemia in ESRD.
Conclusions:
- Troponin I is the most sensitive and specific biomarker for diagnosing ischemic heart disease in patients with end-stage renal disease.
- Troponin I facilitates accurate risk stratification and bedside diagnosis in this high-risk group.
Abstract:
Coronary artery disease is highly prevalent in patients with end-stage renal disease, and accounts for much of their observed morbidity and mortality. Despite this, diagnosing myocardial disease in this population remains problematic, because many patients present with abnormal baseline electrocardiograms, frequently compounded by silent or atypical symptoms. Conventionally used enzymatic markers of cardiac injury have not resolved this dilemma because of their poor specificity in end-stage renal disease. In particular, nonspecific elevations in creatinine kinase-muscle brain enzyme, a widely accepted marker of cardiac injury, have been consistently observed in the absence of other demonstrable evidence for cardiac injury. Recently, the cardiac troponins (troponin I and troponin T) have emerged as more sensitive markers for cardiac ischemia, facilitating rapid bedside diagnosis and early risk stratification. Unfortunately, cardiac troponin T shows poor specificity in end-stage renal disease, possibly because of variable expression in extracardiac tissues. On the other hand, troponin I consistently maintains a high sensitivity and specificity, and is the most sensitive marker for ischemic heart disease in this patient population.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...